With the PBS-listing of calcitonin gene-related peptide (CGRP) inhibitors1,2 for the preventive treatment of chronic migraine (Authority Required – Streamline), neurologists now have wider access to treatments specifically developed for migraine. The limbic spoke to leading Australian headache specialists Dr Bronwyn Jenkins from Sydney and Dr Christina Sun-Edelstein from Melbourne about their experience with CGRP ...
Early experience and clinical tips for the use of CGRP inhibitors in migraine prevention
14 Oct 2021
Sponsored by Eli Lilly Australia Pty Ltd